Shandong Liaocheng e hua Pharmaceutical Co., Ltd is largest of pharmaceutic adjuvant in Asia. Main products of the company include: Microcrystalline cellulose,  Hypromellose, Low-Substituted hydroxypropyl cellulose and others, in a total of more than 30. Its quality meets the pharmacopeia standards of such countries asChina, theUnited States, Europe andJapan, and it has been the first in the industry to become the supplier of more than 1,500 domestic pharmaceutical enterprises and international famous pharmaceutical enterprises as follows: Xian-Janssen, Shanghai JNJ, GSK, Pfizer,  Roche, and etc. Its products are exported to more than 10 countries, such as theUnitedStates,Britain,Japan,AustraliaandRussia.

  The company has four patents for invention and Famous Trademark in Shandong Province and has obtained the first enterprise invention award in ShandongProvince. It is a national new high-tech enterprise, enterprise in Shandong Province that honors the contract and keeps the promise, And many other honors,It undertook 5 national, provincial and municipal key projects during the period of the “12th Five-Year”. The “construction project of pharmaceutic adjuvant with an annual output of 22,000 tons” in Liaocheng New & High-tech Development Zone is approved as “key provincial construction project in 2016” by People’s Government of Shandong Province. The project is infused with the concept of Made in China 2025 strategy to realize the modern production conditions of “lean production, intelligent management, automatic control and mechanized operation". Focusing on the interests of the customers, the company is constantly improving the quality of value-added services. E Hua Pharmaceutical are striving for human health and the rise of Chinese pharmaceutic adjuvant with wisdom, hard-working and industrious.




               E Hua Pharmaceutic Adjuvant – the leader of Chinese pharmaceutic adjuvant